Keyphrases
Liposomes
100%
Autoimmune Disease
100%
Minocycline
100%
Central Nervous System
100%
Polyethylene Glycol
100%
Matrix metalloproteinase-9 (MMP-9)
46%
Experimental Autoimmune
30%
Leukocytes
23%
Multiple Sclerosis
15%
Spinal Cord
7%
Intravenous Injection
7%
Potent Inhibitor
7%
Peripheral Blood Mononuclear Cells
7%
Cell number
7%
Pharmacotherapy
7%
Treatment Group
7%
Splenocytes
7%
Promising Treatment
7%
Targeted Treatment
7%
Disease Activity
7%
Intraperitoneal Injection
7%
Effective Alternative
7%
Kinetic Study
7%
Human Patients
7%
Matrix Metalloproteinase Inhibitors
7%
Expression Activity
7%
Potential Adverse Effects
7%
Proteolytic Activity
7%
Calcium Chloride
7%
Long-circulating
7%
Liposome Preparation
7%
Tetracycline Derivatives
7%
Absolute Amount
7%
Time Kinetics
7%
Gaining Access
7%
Pharmacology, Toxicology and Pharmaceutical Science
Liposome
100%
Autoimmune Disease
100%
Macrogol
100%
Minocycline
100%
Gelatinase B
46%
Multiple Sclerosis
15%
Pharmacotherapy
7%
Treatment Group
7%
Disease Activity
7%
Intraperitoneal Injection
7%
Bioavailability
7%
Calcium Chloride
7%
Tetracycline Derivative
7%